Gene Therapy

Flux and Uncertainty in the CRISPR Patent Landscape

flux-and-uncertainty-in-the-crispr-patent-landscape

In May 2012, the University of California, Berkeley, filed a patent application for biochemist Jennifer Doudna and the University of Vienna’s Emmanuelle Charpentier, then of Umeå University in Sweden, based on their seminal observation that the bacterial CRISPR-Cas9 gene-editing system can be used to target different sequences of DNA by reprogramming the system’s small homing […]

Biomarker Tests for Molecularly Targeted Therapies

Print

The Key to Unlocking Precision Medicine NEJM   An IOM committee focused on biomarkers for molecularly targeted therapies has issued recommendations about regulatory, reimbursement, and clinical practice issues, in order to guide precision medicine in advancing the care of patients with cancer and other diseases. This article was published on June 1, 2016, at NEJM.org. Disclosure forms […]

The Lab Results Are In: Genes Might Be to Blame for Retrievers’ Obesity

Puppies_1

  If you’ve ever had a Labrador retriever, you know about one of the breed’s notable traits: an unrelenting appetite. The dogs will devour anything from socks to rocks, and given the chance, they can be prone to eat themselves into obesity. By one estimate, nearly 60 percent of all Labradors are overweight or obese. […]

Gene drives aren’t ready for the wild, report concludes

121215_CRISPR_opener

Mosquitoes and other organisms normally have a 50 percent chance of passing along a gene to an offspring. A gene drive copies and pastes itself into chromosomes from both parents, ensuring it gets passed on more often. Mosquitoes and invasive species can rest easy — for now. Genetic technology called gene drives could wipe out […]

First Gene Therapy for Children is Approved in Europe

34C9C17400000578-3617260-image-a-14_1464683801507

Radical treatment for rare ‘bubble boy’ disorder has a 100% survival rate The European Commission has given approval for British drug firm GlaxoSmithKline to produce the world’s first gene therapy treatment for children. GSK will produce Strimvelis, the first stem cell gene therapy to treat patients with severe combined immunodeficiency caused by adenosine deaminase deficiency […]

Genetically engineered immune cells are saving the lives of cancer patients

engineeringcellsfinal2

Immune Engineering – That may just be the start The doctors looking at Layla Richards saw a little girl with leukemia bubbling in her veins. She’d had bags and bags of chemotherapy and a bone marrow transplant. But the cancer still thrived. By last June, the 12-month-old was desperately ill. Her parents begged—wasn’t there anything? […]

THE QUEST TO SEQUENCE THE GENOME OF A VOLCANO-DWELLING WORM

volcano-worm

On São Miguel Island, in the Azores archipelago in the middle of the North Atlantic, lives a curious Brazilian expat. Known as Pontoscolex corethrurus, this tropical worm cannot tolerate the isle’s temperate climate. And yet it survives there in two areas: in artificially warmed pineapple greenhouses and the soil within an active volcano. Read more here

The Gene Editors Are Only Getting Started

the-gene-editors-are-only-getting-started

Rewriting the code of life has never been so easy. In 2012 scientists demonstrated a new DNA-editing technique called Crispr. Five years later it is being used to cure mice with HIV and hemophilia. Read more here.

Breakthrough DNA Editor Born of Bacteria

breakthrough-dna-editor-born-of-bacteria

On a November evening last year, Jennifer Doudna put on a stylish black evening gown and headed to Hangar One, a building at NASA’s Ames Research Center that was constructed in 1932 to house dirigibles. Read more here.

Should we bring extinct species back from the dead?

should-we-bring-extinct-species-back-from-the-dead

Earth is in the midst of its sixth mass extinction: Somewhere between 30 and 159 species disappear every day, thanks largely to humans, and more than 300 types of mammals, birds, reptiles, and amphibians have vanished since 1500. Read more here.

CRISPR Patent Outcome Won’t Slow Innovation

crispr-patent-outcome-wont-slow-innovation

Last week a panel of judges at the U.S. Patent and Trademark Office in Alexandria, Virginia, heard arguments as to who should own the rights to the century’s biggest biotechnology invention to date, a precise gene-editing system called CRISPR-Cas9 that has the potential to treat serious human genetic disorders and create designer crops that resist […]